Drug Repurposing: New Treatments for Zika Virus Infection?

Trends Mol Med

Division of Infectious Disease, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232, USA; Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA; Research Medicine, VA Tennessee Valley Healthcare System, Nashville, TN 37212, USA.

Published: November 2016

To date, no antiviral agents have been approved for treating Zika virus (ZIKV) infection. Two recent drug-repurposing studies published in Cell Host & Microbe and Nature Medicine demonstrated that screening FDA-approved drugs for antiviral activity is a promising strategy for identifying therapeutics with novel activity against ZIKV infection.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molmed.2016.09.006DOI Listing

Publication Analysis

Top Keywords

zika virus
8
zikv infection
8
drug repurposing
4
repurposing treatments
4
treatments zika
4
virus infection?
4
infection? antiviral
4
antiviral agents
4
agents approved
4
approved treating
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!